Results for tag: "Tumor Specific Antigen"

Tumor Specific Antigens (TSAs) are biomarkers that are used to detect and monitor the presence of cancer in a patient. TSAs are proteins that are produced by tumor cells and are not found in healthy cells. They can be used to detect the presence of cancer in a patient, as well as to monitor the progression of the disease. TSAs can also be used to identify the type of cancer present in a patient, as well as to determine the best course of treatment. TSAs are used in a variety of diagnostic tests, including immunohistochemistry, flow cytometry, and ELISA. They are also used in combination with other biomarkers, such as genetic markers, to provide a more comprehensive picture of the disease. There are a number of companies that are involved in the development and production of TSAs. These include Abcam, Bio-Rad, Cell Signaling Technology, Genentech, and Thermo Fisher Scientific. Show Less Read more